Richmond Pharmacology (RPL) will be attending this month’s 22nd Annual DIA EuroMeeting, taking place 8-10 March 2010 in Monaco.
The DIA Annual EuroMeeting features more than 110 hot-topic sessions across 13 themes and attracts more than 3,000 professionals from the biopharmaceutical industry, contract service organisations, regulatory agencies, health ministries and academia, as well as patients and students worldwide.
Themes are based on an integrated multidisciplinary approach that will generate interest from as many disciplines as possible. This year’s themes include:
Innovation
Staying in Business: How to Make Sure You Comply with All Rules and Regulations
Paediatric Medicines on Their Way to Patients
Decision Making: The Key to Efficient and Effective Drug Development, approval, and access
Paving the Way for Advanced Therapies: Fostering New Generations of Biotechnology-Derived Medicines
Challenges for Switching from Prescription to Non-Prescription Status through the Centralised Procedure
Personalised Medicines: What Is It, Where Do We Stand, and Where Are We Going?
Taking the European Regulatory Infrastructure Forward
Risk Management
The Informed Patient
eHealth
Pharmaceutical Sciences in 2020
Handling Clinical Trials, eSubmissions and Quality Requests
RPL will be exhibiting at this year’s DIA EuroMeeting to inform key decision makers in the industry of our expertise and experience in the field of Early Phase Research. The EuroMeeting is a key event in the calendar and this forum provides an ideal opportunity to meet with existing clients, network and connect with new prospective sponsors. Planning to attend? We look forward to seeing you in Monaco next month!